Laboratoires Leurquin Mediolanum   Report issue

For profit Phase 2 Phase 4
Founded: NEUILLY SUR MARNE France (1955)
Status: No NME R&D (1955)

Organization Overview

First Clinical Trial
2014
NCT02293707
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Mediolanum Cardio Research

Active Ingredients

Drugs in Phase 4 Trials (1)

lithium (lithonate) (1 trial)

Drugs in Phase 2 Trials (1)

gx301 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bipolar Disorder (Phase 4)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2